Car-T Toxicities: Crs And Icans

CAR T-cell toxicity: CRS, ICANS and prolonged cytopenias

VJHemOnc – Video Journal of Hematology & HemOnc

CAR T-cell toxicity: CRS, ICANS and prolonged cytopenias

CAR-T Toxicities: CRS and ICANS

UW Health Pharmacy

Strategies to minimize the occurrence of CRS and ICANS in patients treated with CAR-T therapy

VJHemOnc – Video Journal of Hematology & HemOnc

Management of CRS and ICANS after CAR-T therapy for ALL

VJHemOnc – Video Journal of Hematology & HemOnc

Managing Acute Toxicities of CAR T-cell Therapy

Blood Cancer Talks Podcast

Mechanisms and management of short- and long-term CAR-T toxicities

VJHemOnc – Video Journal of Hematology & HemOnc

CAR T-cell therapy: CRS and adverse effects

VJHemOnc – Video Journal of Hematology & HemOnc

CTTC BMT101 Webinar Series: Introduction to CAR-T - PART 2: For Trainees (Dr. Kevin Hay)

Cell Therapy Transplant Canada

Lymphoma: Overview of Chimeric Antigen Receptor (CAR) T cells

Harvard Medical School Continuing Education

What is ICANS?

HealthTree University Myeloma

Management of CAR-T Toxicities: CRS, Neurological, Cytopenias, Infection

Blood Cancers Today

Managing and treating CRS, neurological toxicity and cytopenias associated with CAR-T therapy

VJHemOnc – Video Journal of Hematology & HemOnc

Investigating the co-occurrence of CRS and ICANS after CAR-T therapy & the need for novel therapies

VJHemOnc – Video Journal of Hematology & HemOnc

Treating CRS and ICANS: current approaches and future outlooks

VJHemOnc – Video Journal of Hematology & HemOnc

CAR-T: Management of Cytokine Release Syndrome and Neurotoxicity

Dr. Sehgal on Managing CRS and Neurotoxicity From CAR T-Cell Therapy

Managing CRS and neurotoxicities associated with CAR-T in ZUMA-3

VJHemOnc – Video Journal of Hematology & HemOnc

Managing CAR T-Cell Therapy Toxicity

Siltuximab for the management of CAR-T toxicities: a multicenter retrospective study

VJHemOnc – Video Journal of Hematology & HemOnc